Enlivex Therapeutics Ltd. (ENLV)
4.59
-0.14 (2.96%)
Upcoming Events
Latest Headlines
Form 6-K Enlivex Ltd. For: Jul 20
July 20, 2026 8:02 AM - SEC Filing
FDA grants RMAT designation to Enlivex's Allocetra for knee OA
July 13, 2026 8:01 AM - StreetInsider
Form 6-K Enlivex Ltd. For: Jul 13
July 13, 2026 8:00 AM - SEC Filing
Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra™ in Age-Related Knee Osteoarthritis
July 13, 2026 8:00 AM - Globe NewsWire
Enlivex Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Allocetra™ in Age-Related Knee Osteoarthritis
July 13, 2026 8:00 AM - StreetInsider
Exclusive: FDA grants RMAT designation to Enlivex’s Allocetra for knee OA
July 13, 2026 7:06 AM - StreetInsider
Form 6-K Enlivex Ltd. For: Jul 07
July 7, 2026 8:02 AM - SEC Filing
Enlivex sets 1-for-15 reverse stock split effective July 9
July 7, 2026 8:00 AM - StreetInsider
Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026
July 7, 2026 8:00 AM - StreetInsider
Enlivex RAIN token listed on Gate cryptocurrency exchange
June 24, 2026 8:02 AM - StreetInsider
Form 6-K Enlivex Ltd. For: Jun 24
June 24, 2026 8:01 AM - SEC Filing
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on Gate, One of the World's Largest Cryptocurrency Exchanges by Spot Trading Volume
June 24, 2026 8:01 AM - Globe NewsWire
Form 6-K Enlivex Ltd. For: Jun 22
June 22, 2026 8:50 AM - SEC Filing
Enlivex receives Australian patent for Allocetra osteoarthritis treatment
June 15, 2026 8:03 AM - StreetInsider
Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis
June 15, 2026 8:00 AM - StreetInsider
ENLIVEX TO PRESENT QUALITY LONGEVITY MODEL POWERED BY PREDICTION MARKETS TREASURY AT PROOF OF TALK 2026
June 2, 2026 8:00 AM - StreetInsider
Enlivex to present Allocetra knee osteoarthritis data at EULAR congress
June 1, 2026 8:00 AM - StreetInsider
Allocetra Shows Durable 6-Month Efficacy in Knee Osteoarthritis Phase IIa Trial; Oral Presentation at EULAR 2026
June 1, 2026 8:00 AM - StreetInsider
Form 6-K Enlivex Ltd. For: May 28
May 28, 2026 8:05 AM - SEC Filing
Enlivex reports $1.16 billion RAIN token holdings as of May 27
May 28, 2026 8:01 AM - StreetInsider
Enlivex reports $1.16 billion RAIN token holdings value
May 28, 2026 8:00 AM - StreetInsider
Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.16 Billion; Rain Foundation Appoints Industry Leaders to Advisory Board
May 28, 2026 8:00 AM - StreetInsider
Form 6-K Enlivex Ltd. For: May 27
May 27, 2026 8:05 AM - SEC Filing
Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity
May 27, 2026 8:00 AM - Globe NewsWire
Form 6-K Enlivex Ltd. For: May 18
May 18, 2026 8:02 AM - SEC Filing
Enlivex doses first US patient in phase 2b knee osteoarthritis trial
May 18, 2026 8:01 AM - StreetInsider
Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
May 18, 2026 8:00 AM - Globe NewsWire
Form 6-K Enlivex Ltd. For: May 15
May 15, 2026 4:22 PM - SEC Filing
Enlivex receives Nasdaq minimum bid price deficiency notice
May 15, 2026 4:17 PM - StreetInsider
Enlivex Announces Receipt of Nasdaq Minimum Bid Price Notification
May 15, 2026 4:10 PM - Globe NewsWire
Form 424B3 Enlivex Ltd.
May 1, 2026 4:17 PM - SEC Filing
Form EFFECT Enlivex Ltd.
May 1, 2026 9:29 AM - SEC Filing
ENLV's RAIN token lists on HTX cryptocurrency exchange
April 30, 2026 8:33 AM - StreetInsider
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange
April 30, 2026 8:30 AM - StreetInsider
Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million
April 28, 2026 8:30 AM - Globe NewsWire
Full Article List
